ACE2 and COVID-19: Thus, considering that SARS-CoV-2 binds to ACE2 and enters infected cells [43, 44], reducing the ACE2 expression [45], overactivation of the renin-angiotensin system may also increase the risk of adverse events in patients with COVID-19 and diabetes.